Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes

Archives of Dermatological Research

Volumn 299, Issue 7, 2007, Pages 345-351

  Ikeda, Yoshiki ^a,b   Takei, Hisato ^a   Matsumoto, Chinami ^a   Mase, Akihito ^a   Yamamoto, Masahiro ^a,b   Takeda, Shuichi ^a   Ishige, Atsushi ^b   Watanabe, Kenji ^b  

^a Tsumura Research Institute   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; CD8+ T cells; Contact dermatitis; Long term; Substance P

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; SPANTIDE; SUBSTANCE P; SUBSTANCE P ANTAGONIST;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; STATISTICAL ANALYSIS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DINITROFLUOROBENZENE; FEMALE; INFLAMMATION; MICE; MICE, INBRED BALB C; SUBSTANCE P;

EID: 34548022115     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0767-4     Document Type: Article

References (37)

1. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D (1996) Skin-nervous system interactions. J Invest Dermatol 106:198-204
2. Black PH (2002) Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622-653
3. Bunce C, Bell EB (1997) CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J Exp Med 185:767-776
4. Buske-Kirschbaum A, Geiben A, Hellhammer D (2001) Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 70:6-16
5. Calvo CF, Chavanel G, Senik A (1992) Substance P enhances IL-2 expression in activated human T cells. J Immunol 148:3498-3504
6. Fantini F, Pincelli C, Romualdi P, Donatini A, Giannetti A (1992) Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1:127-128
7. Gautam SC, Matriano JA, Chikkala NF, Edinger MG, Tubbs RR (1991) L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cell Immunol 135:27-41
8. Giannetti A, Fantini F, Cimitan A, Pincelli C (1992) Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 176:90-92
9. Giannetti A, Girolomoni G (1989) Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121:681-688
10. Gocinski BL, Tigelaar RE (1990) Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144:4121-4128
11. Goetzl EJ, Chernov T, Renold F, Payan DG (1985) Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135:802s-805s
12. Harrison S, Geppetti P (2001) Substance p. Int J Biochem Cell Biol 33:555-576
13. Heyer GR, Hornstein OP (1999) Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 26:77-86
14. Huang CH, Kuo IC, Xu H, Lee YS, Chua KY (2003) Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J Invest Dermatol 121:289-293
15. Katsuno M, Aihara M, Kojima M, Osuna H, Hosoi J, Nakamura M, Toyoda M, Matsuda H, Ikezawa Z (2003) Neuropeptides concentrations in the skin of a murine (NC/Nga mice) model of atopic dermatitis. J Dermatol Sci 33:55-65
16. Kim KH, Park KC, Chung JH, Choi HR (2003) The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 32:115-124
17. Kondo S, Beissert S, Wang B, Fujisawa H, Kooshesh F, Stratigos A, Granstein RD, Mak TW, Sauder DN (1996) Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J Invest Dermatol 106:993-1000
18. Lambrecht BN, Germonpre PR, Everaert EG, Carro-Muino I, De Veerman M, de Felipe C, Hunt SP, Thielemans K, Joos GF, Pauwels RA (1999) Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 29:3815-3825
19. Marriott I, Bost KL (2001) Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol 114:131-141
20. Marriott I, Mason MJ, Elhofy A, Bost KL (2000) Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol 102:163-171
21. Nakano Y (2004) Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress. Br J Dermatol 151:50-64
22. Niizeki H, Kurimoto I, Streilein JW (1999) A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity. J Invest Dermatol 112:437-442
23. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F (2004) The role of substance P in inflammatory disease. J Cell Physiol 201:167-180
24. Ohmura T, Hayashi T, Satoh Y, Konomi A, Jung B, Satoh H (2004) Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 491:191-194
25. Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ (1984) Substance P recognition by a subset of human T lymphocytes. J Clin Invest 74:1532-1539
26. Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE (2006) Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 126:1937-1947
27. Santoni G, Perfumi MC, Spreghini E, Romagnoli S, Piccoli M (1999) Neurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats. J Neuroimmunol 93:15-25
28. Scholzen TE, Stander S, Riemann H, Brzoska T, Luger TA (2003) Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol 170:3866-3873
29. Scholzen TE, Steinhoff M, Sindrilaru A, Schwarz A, Bunnett NW, Luger TA, Armstrong CA, Ansel JC (2004) Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J 18:1007-1009. Epub 2004 April 14
30. Shepherd AJ, Beresford LJ, Bell EB, Miyan JA (2005) Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P. J Neuroimmunol 164:115-123
31. Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M (1997) Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 289:125-131
32. Surh CD, Boyman O, Purton JF, Sprent J (2006) Homeostasis of memory T cells. Immunol Rev 211:154-163
33. Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ (1992) Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90:613-622
34. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71-79
35. Wahlgren CF (1999) Itch and atopic dermatitis: an overview. J Dermatol 26:770-779
36. Wang Y, Huang DS, Giger PT, Watson RR (1994) Influence of chronic dietary ethanol on cytokine production by murine splenocytes and thymocytes. Alcohol Clin Exp Res 18:64-70
37. Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183:1001-1012